Regulatory updates are needed to prevent the commercialization of islet transplantation in the United States

the “Islet for US Collaborative”

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)2620-2622
Number of pages3
JournalAmerican Journal of Transplantation
Volume21
Issue number7
DOIs
StatePublished - Jul 2021

Bibliographical note

Funding Information:
PW is supported by US Public Health Service Grant P30DK020595. We acknowledge contributions and support from the remaining members of the “Islets for US Collaborative”: Marwan S. Abouljoud, MD (Henry Ford Hospital, Detroit, MI), Kenneth Andreoni, MD (University of Florida, Gainesville, FL), Dixon B. Kaufman, MD, PhD and Jon Odorico, MD (University of Wisconsin, Madison, WI), Peter Stock, MD, PhD (University of California San Francisco, San Francisco, CA), James F. Markmann MD, PhD, and Jason Gaglia, MD (Harvard Medical School, Boston, MA), Joseph Leventhal, MD, PhD, (Northwestern University, Chicago, IL), Lloyd Ratner MD, Mark A. Hardy, MD, Beth Schrope, MD, and Yossi Schwartz, MD (Columbia University, New York, NY), Louis Philipson, MD, PhD, Raghavendra G. Mirmira, MD, PhD, John Fung, MD, PhD, Michael Millis, MD, Yolanda Becker, MD, Michelle A. Josephson, MD, Michael Charlton, MD, Amittha Wickrema, PhD, Karolina Golab, PhD and Kumar Jayant, MD, PhD (University of Chicago, Chicago, IL), Melena Bellin, MD and Raja Kandaswamy, MD (University of Minnesota, Minneapolis, MN), Peter L. Abrams MD and Wanxing Cui MD, PhD (MedStar Georgetown, Washington, DC), Marlon Levy MD (Virginia Commonwealth, Richmond, VA), Rodolfo Alejandro MD and David Baidal MD (University of Miami, Miami, FL), John Buse, MD PhD and Chirag S. Desai, MD (University of North Carolina, Chapel Hill, NC), Martin Wijkstrom MD (University of Pittsburg, Pittsburg, PA), R. Paul Robertson, MD (University of Washington, Seattle, WA), Robert J. Stratta MD (Wake Forest, Winston‐Salem, NC), Jonathan A Fridell MD (Indiana University, Indianapolis, IN), Tomasz Kozlowski MD (Oklahoma University, Oklahoma City, OK), Shakir Hussain MD (Detroit Medical Center, Detroit, MI), Abbas Rana MD (Baylor Medical College, Houston, TX), Robert Harland MD (University of Arizona, Tucson, AZ), Fouad Kandeel, MD, PhD (City of Hope, Duarte, CA), David Mulligan, MD (Yale University, New Haven, CT), Oyedolamu K. Olaitan, MD (Rush University, Chicago, IL), Ling‐Xin Chen, MD (UC Davis, Sacramento, CA), Jason Wellen, MD (Washington University, St. Louis, MI), Bashoo Naziruddin, PhD (Baylor University Medical Center, Dallas, TX), Appakalai N. Balamurugan, PhD (University of Cincinnati, Cincinnati, OH), Xunrong Luo, MD, PhD (Duke University Durham, NC), Silke Niederhaus, MD (University of Maryland, Baltimore, MD), Rachael C. Forbes, MD (Vanderbilt University Nashville, TN). , , ,

Funding Information:
PW is supported by US Public Health Service Grant P30DK020595. We acknowledge contributions and support from the remaining members of the ?Islets for US Collaborative?: Marwan S. Abouljoud, MD (Henry Ford Hospital, Detroit, MI), Kenneth Andreoni, MD (University of Florida, Gainesville, FL), Dixon B. Kaufman, MD, PhD and Jon Odorico, MD (University of Wisconsin, Madison, WI), Peter Stock, MD, PhD (University of California San Francisco, San Francisco, CA), James F. Markmann MD, PhD, and Jason Gaglia, MD (Harvard Medical School, Boston, MA), Joseph Leventhal, MD, PhD, (Northwestern University, Chicago, IL), Lloyd Ratner MD, Mark A. Hardy, MD, Beth Schrope, MD, and Yossi Schwartz, MD (Columbia University, New York, NY), Louis Philipson, MD, PhD, Raghavendra G. Mirmira, MD, PhD, John Fung, MD, PhD,, Michael Millis, MD, Yolanda Becker, MD, Michelle A. Josephson, MD, Michael Charlton, MD, Amittha Wickrema, PhD, Karolina Golab, PhD and Kumar Jayant, MD, PhD (University of Chicago, Chicago, IL), Melena Bellin, MD and Raja Kandaswamy, MD (University of Minnesota, Minneapolis, MN), Peter L. Abrams MD and Wanxing Cui MD, PhD (MedStar Georgetown, Washington, DC), Marlon Levy MD (Virginia Commonwealth, Richmond, VA), Rodolfo Alejandro MD and David Baidal MD, (University of Miami, Miami, FL), John Buse, MD PhD and Chirag S. Desai, MD (University of North Carolina, Chapel Hill, NC), Martin Wijkstrom MD (University of Pittsburg, Pittsburg, PA), R. Paul Robertson, MD (University of Washington, Seattle, WA), Robert J. Stratta MD, (Wake Forest, Winston-Salem, NC), Jonathan A Fridell MD (Indiana University, Indianapolis, IN), Tomasz Kozlowski MD (Oklahoma University, Oklahoma City, OK), Shakir Hussain MD (Detroit Medical Center, Detroit, MI), Abbas Rana MD (Baylor Medical College, Houston, TX), Robert Harland MD (University of Arizona, Tucson, AZ), Fouad Kandeel, MD, PhD (City of Hope, Duarte, CA), David Mulligan, MD (Yale University, New Haven, CT), Oyedolamu K. Olaitan, MD (Rush University, Chicago, IL), Ling-Xin Chen, MD (UC Davis, Sacramento, CA), Jason Wellen, MD (Washington University, St. Louis, MI), Bashoo Naziruddin, PhD (Baylor University Medical Center, Dallas, TX), Appakalai N. Balamurugan, PhD (University of Cincinnati, Cincinnati, OH), Xunrong Luo, MD, PhD (Duke University Durham, NC), Silke Niederhaus, MD (University of Maryland, Baltimore, MD), Rachael C. Forbes, MD (Vanderbilt University Nashville, TN).

Keywords

  • diabetes: type 1
  • editorial/personal viewpoint
  • ethics and public policy
  • insurance – public
  • islet transplantation
  • islets of Langerhans
  • law/legislation
  • quality of care/care delivery

Cite this